209 related articles for article (PubMed ID: 33619882)
1. Depressed β-adrenergic inotropic responsiveness and intracellular calcium handling abnormalities in Duchenne Muscular Dystrophy patients' induced pluripotent stem cell-derived cardiomyocytes.
Mekies LN; Regev D; Eisen B; Fernandez-Gracia J; Baskin P; Ben Jehuda R; Shulman R; Reiter I; Palty R; Arad M; Gottlieb E; Binah O
J Cell Mol Med; 2021 Apr; 25(8):3922-3934. PubMed ID: 33619882
[TBL] [Abstract][Full Text] [Related]
2. Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy.
Li Y; Zhang S; Zhang X; Li J; Ai X; Zhang L; Yu D; Ge S; Peng Y; Chen X
Cardiovasc Res; 2014 Jul; 103(1):60-71. PubMed ID: 24812281
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
[TBL] [Abstract][Full Text] [Related]
4. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
5. The intracellular Ca2+ concentration is elevated in cardiomyocytes differentiated from hiPSCs derived from a Duchenne muscular dystrophy patient.
Tsurumi F; Baba S; Yoshinaga D; Umeda K; Hirata T; Takita J; Heike T
PLoS One; 2019; 14(3):e0213768. PubMed ID: 30875388
[TBL] [Abstract][Full Text] [Related]
6. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency.
Pioner JM; Santini L; Palandri C; Langione M; Grandinetti B; Querceto S; Martella D; Mazzantini C; Scellini B; Giammarino L; Lupi F; Mazzarotto F; Gowran A; Rovina D; Santoro R; Pompilio G; Tesi C; Parmeggiani C; Regnier M; Cerbai E; Mack DL; Poggesi C; Ferrantini C; Coppini R
Front Physiol; 2022; 13():1030920. PubMed ID: 36419836
[TBL] [Abstract][Full Text] [Related]
7. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
8. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell-Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy.
Kamdar F; Das S; Gong W; Klaassen Kamdar A; Meyers TA; Shah P; Ervasti JM; Townsend D; Kamp TJ; Wu JC; Garry MG; Zhang J; Garry DJ
J Am Coll Cardiol; 2020 Mar; 75(10):1159-1174. PubMed ID: 32164890
[TBL] [Abstract][Full Text] [Related]
10. Intracellular calcium handling in ventricular myocytes from mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H846-55. PubMed ID: 17012353
[TBL] [Abstract][Full Text] [Related]
11.
Jimenez-Vazquez EN; Arad M; Macías Á; Vera-Pedrosa ML; Cruz FM; Gutierrez LK; Cuttitta AJ; Monteiro da Rocha A; Herron TJ; Ponce-Balbuena D; Guerrero-Serna G; Binah O; Michele DE; Jalife J
Elife; 2022 Jun; 11():. PubMed ID: 35762211
[TBL] [Abstract][Full Text] [Related]
12. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
[TBL] [Abstract][Full Text] [Related]
13. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
Eisen B; Binah O
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
[TBL] [Abstract][Full Text] [Related]
14. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
[TBL] [Abstract][Full Text] [Related]
15. Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy Patients.
Willi L; Abramovich I; Fernandez-Garcia J; Agranovich B; Shulman M; Milman H; Baskin P; Eisen B; Michele DE; Arad M; Binah O; Gottlieb E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077200
[TBL] [Abstract][Full Text] [Related]
16. Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy.
Souidi M; Resta J; Dridi H; Sleiman Y; Reiken S; Formoso K; Colombani S; Amédro P; Meyer P; Charrabi A; Vincenti M; Liu Y; Soni RK; Lezoualc'h F; Stéphane Blot DVM; Rivier F; Cazorla O; Parini A; Marks AR; Mialet-Perez J; Lacampagne A; Meli AC
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):536-551. PubMed ID: 38221511
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of intracellular Ca
Sato M; Shiba N; Miyazaki D; Shiba Y; Echigoya Y; Yokota T; Takizawa H; Aoki Y; Takeda S; Nakamura A
Biochem Biophys Res Commun; 2019 Nov; 520(1):179-185. PubMed ID: 31585729
[TBL] [Abstract][Full Text] [Related]
18. Calcium current properties in dystrophin-deficient ventricular cardiomyocytes from aged mdx mice.
Rubi L; Todt H; Kubista H; Koenig X; Hilber K
Physiol Rep; 2018 Jan; 6(1):. PubMed ID: 29333726
[TBL] [Abstract][Full Text] [Related]
19. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.
Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y
Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626
[TBL] [Abstract][Full Text] [Related]
20. Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
Hallas T; Eisen B; Shemer Y; Ben Jehuda R; Mekies LN; Naor S; Schick R; Eliyahu S; Reiter I; Vlodavsky E; Katz YS; Õunap K; Lorber A; Rodenburg R; Mandel H; Gherghiceanu M; Binah O
J Cell Mol Med; 2018 Feb; 22(2):913-925. PubMed ID: 29193756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]